劉祐岑醫師實驗室提供癲癇及相關疾病基因檢測服務如下：

威爾森氏症突變檢測 (Wilson disease/ATP7B)

腦血管屏障葡萄糖輸送缺陷突變檢測(Glucose Transport 1 Deficiency Syndrome/SLC2A1)

蕾特氏症突變檢測 (Rett syndrome/MECP2)

陣發性動作誘發型動作障礙突變檢測(paroxysmal kinesigenic dyskinesia/PRRT2)

平腦症突變檢測 (lissencephaly/LIS1, DCX)

結節性硬化症次世代定序突變檢測 (TSC1, TSC2)

神經纖維瘤次世代定序突變檢測 (NF1, NF2)

卓飛症候群次世代定序突變檢測(Dravet syndrome, SCN1A)

癲癇次世代定序突變檢測 (Epilepsy)

腦皮質發育異常次世代定序突變檢測 (MCD)

巴金森氏症/肌張力異常/其他動作障礙次世代定序突變檢測(Parkinson disease/Dystonia/other movement disorders)

海綿竇血管瘤次世代定序突變檢測 (Cerebral cavernous malformation)

如欲聯絡檢測時間，或有相關問題詢問，請於週一至週五上午9:00-12:00或下午1:30-5:30來電神經內科腦波室找蔡護理師或陳護理師或撥打手機0972-035-675

得獎紀錄:

2023 (112年)台灣癲癇醫學會研究論文獎第二名。

2021亞太神經學大會(Asian Oceanian Congress of Neurology)最佳論文及口頭發表。

2020台灣神經學學會年會論文口頭發表最佳論文及口頭發表。

2021 (110年)第17屆榮總台灣聯合大學合作研究計畫優良論文第二名。

108學年度台北榮民總醫院實習醫學生票選最佳主治醫師。

2017 (106年)臺北榮民總醫院PGY票選優良教學醫師

2017 (106年)台灣癲癇醫學會研究論文獎第一名。

國立陽明交通大學醫學系109學年上下學期優良教師。

國立陽明大學醫學系105~108學年上下學期優良教師。

國立陽明大學醫學系105~107學年PBL引導老師優良教師

論文著作

1. Monogenic causes in familial stroke across intracerebral hemorrhage and ischemic stroke subtypes identified by whole exome sequencing. Chang LH, Chi NF, Chen CY, Lin YS, Hsu SL, Ysai JY, Hunag HC, Lin CJ, Chung CP, Tung CY, Jeng CJ, Lee YC, Liu YT*#, Lee IH*#. Cell Mol Neurobiol. 2022 Dec 29. doi: 10.1007/s10571-022-01315-3. Online ahead of print. (*Corresponding author, # equal contribution)
2. Plasma Matrix Metalloproeteinase-9 Is Associated with Seizure and Angioarchitecture Changes in Brain Arteriovenous Malformations. Liu YT, Lee CC, Chang FC, Liou KD, Lin CC*. 2022 Oct;59(10):5925-5934.
3. Clinical characteristics and long-term outcome of cerebral cavernous malformations-related epilepsy. Shih YC, Chou CC, Peng SJ, Yu HY, Hsu SPC, Lin CF, Lee CC, Yang HC, Chen YC, Kwan SY, Chen C, Wang SJ, Lin CJ, Lirng JF, Shih YH, Yen DJ, Liu YT*. Epilepsia. 2022 Aug;63(8):2056-2067.(SCI)
4. Novel Lissencephaly-Associated DCX Variants in the C-terminal DCX Domain Affect Microtubule Binding and Dynamics. Lin JR#, Cheng JF#, Liu YT, Hsu TR, Lin KM, Chen C, Lin CL, Tsai MH, Tsai JW*. Epilepsia. 2022 May;63(5):1253-1265.(SCI)
5. Cellular secretion and cytotoxicity of transthyretin mutant proteins underlie late onset amyloidosis and neurodegeneration. R B Ibrahim, JW Tsai*, YT Liu*, et al. Cell Mol Life Sci. (2020) 77:1421–1434.
6. Biophysical characterization and pharmacological modulation of Transthyretin Ala97Ser mutant. YT Liu, KP Lin*, TY Yu*, et al. Ann Clin Transl Neurol. 2019 Oct;6(10):1961-1970.
7. Novel SCA19/22-associated KCND3 mutations disrupt human KV4.3 protein biosynthesis and channel gating. Hsiao CT, Fu SJ, Liu YT, Soong BW*, Jeng CJ*, et al. Hum Mutat. 2019 Nov;40(11):2088-2107.
8. Clinical and genetic profiles of hereditary transthyretin amyloidosis in Taiwan. Chao HC, Liao YC, Liu YT, Guo YC, Chang FP, Lee YC*, Lin KP*. Ann Clin Transl Neurol. 2019 Apr 9;6(5):913-922.
9. PRRT2 Missense Mutations Cluster near C-terminus and Frequently Lead to Protein Mislocalization. Tsai MH, Nian FS, Hsu MH, Liu WS, Liu YT, Liu C, Lin PH, Hwang DY, Chuang YC, Tsai JW*. Epilepsia. 2019 May;60(5):807-817.
10. Contributions of Animal Models to the Mechanisms and Therapies of Transthyretin Amyloidosis. Ibrahim RB, Liu YT, Yeh SY, Tsai JW. Front Physiol. 2019 Apr 2;10:338.
11. PDXK mutations cause polyneuropathy responsive to PLP supplementation. Chelban V, Liu YT, Houlden H*, et al ; Care4Rare Canada Consortium; SYNaPS Study Group. Ann Neurol. 2019 Aug;86(2):225-240.
12. Aberrant sensory gating of the primary somatosensory cortex contributes to the motor circuit dysfunction in paroxysmal kinesigenic dyskinesia. Liu YT, Hsiao FJ*, et al. Front Neurol. 2018 Oct 15;9:831.
13. Clinical and Biophysical Characterization of Nineteen GJB1 Mutations. Tsai PC, Yang DM, Liao YC, Chiu YU, Kuo HC, Su YP, Guo YC, Soong BW, Lin KP, Liu YT*(Co-corresponding Author), Lee YC*. Ann Clin Transl Neurol. 2016 Sep 1;3(11):854-865.
14. PRRT2 mutations lead to neuronal dysfunction and neurodevelopmental defects. Liu YT, Nian FS, Chou WJ, Tai CY, Kwan SY, Chen C, Kuo PW, Lin PH, Chen CY, Lee YC, Soong BW*, Tsai JW*. Oncotarget. 2016 Jun 28;7(26):39184-39196. (SCI)
15. What we have learned from the next generation sequencing: contributions to the genetic diagnoses and understanding of pathomechanisms of neurodegenerative diseases. Liu YT, Lee YC, Soong BW. J Neurogenet. 2015 Jun-Sep;29(2-3):103-12.
16. Extended phenotypic spectrum of KIF5A mutations: from spastic paraplegia to axonal neuropathy. Liu YT, Reilly MM* and Houlden H* et al. Neurology. 2014 Jul 9;83(1):1-8.
17. Autosomal-recessive cerebellar ataxia caused by a novel ADCK3 mutation that elongates the protein: clinical, genetic and biochemical characterisation. Liu YT, Houlden H*, et al. J Neurol Neurosurg Psychiatry. 2014 May;85(5):493-8.
18. Novel C12orf65 mutations in patients with axonal neuropathy and optic atrophy. Tucci A, Liu YT, Houlden H*, et al. J Neurol Neurosurg Psychiatry. 2014 May;85(5):486-92.